This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

WellCare, Centene Seen as Potential Takeover Targets of Ascension

NEW YORK ( TheStreet) -- Shares of insurers WellCare (WCG) and Centene (CNC) are rising after an analyst at Leerink speculated that one of the two may be an acquisition target for Ascension Health.

WHAT'S NOTABLE: In a report, dated May 22, Modern Healthcare stated that Ascension Health President and CEO Robert Henkel said during an investor conference organized by Citigroup that his not-for-profit healthcare provider is in talks to acquire an unnamed insurance company that operates in 18 states. Other executives also presenting at the annual conference said they planned to enter or expand in health insurance markets, according to the report.

WHAT'S NEW: In a note to investors today, Leerink analyst Ana Gupte noted that Modern Healthcare's report on Ascension Health referred to its talks being held with "an unnamed 18-state health insurer." Leerink believes the unnamed insurer is most likely WellCare, which is in 18 states with Managed Medicaid and Medicare Advantage. The firm thinks Centene is also a possibility, noting that both CNC and Ascension Health are headquartered in St. Louis, but Gupte added that CNC operates in 20 states. Leerink says it is more positive on shares of WellCare and Centene, as it believes any deal could catalyze more Hospital-Health plan transactions.

PRICE ACTION: In mid-morning trading, shares of WellCare are up more than 3% to $77.06, while Centene is up over 4% to $73.88.

Reporting by Jason Keil.

The Fly provides comprehensive coverage of stock news and Street research and delivers it in real-time. The Fly breaks market-moving news and explains sudden stock movements in a rapid-fire, short-form story format. Follow @theflynews on Twitter. For a free trial, click here.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AAPL $125.74 -0.55%
FB $87.64 0.41%
GOOG $522.48 -0.18%
TSLA $279.30 -0.26%
YHOO $38.56 -2.10%

Markets

DOW 17,683.78 -46.33 -0.26%
S&P 500 2,072.85 -3.93 -0.19%
NASDAQ 4,998.5170 -10.6970 -0.21%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs